We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$892M
AUM Growth
+$114M
Cap. Flow
+$142M
Cap. Flow %
15.87%
Top 10 Hldgs %
24.46%
Holding
5,559
New
1,359
Increased
1,658
Reduced
1,483
Closed
897

Sector Composition

Rank Sector Weight
1 Technology 9.8%
2 Healthcare 7.16%
3 Financials 6.42%
4 Consumer Discretionary 4.97%
5 Communication Services 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRLP
5001
DELISTED
SPRAGUE RESOURCES LP
SRLP
-73
Closed -$2K
RJN
5002
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Energy Total Return
RJN
-900
Closed -$7K
RJZ
5003
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Metals Total Return
RJZ
-200
Closed -$2K
CAPD
5004
DELISTED
iPath Shiller CAPE ETN
CAPD
-10
Closed
BBQ
5005
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
-3,706
Closed -$106K
MNDT
5006
DELISTED
Mandiant, Inc. Common Stock
MNDT
$0 ﹤0.01%
4
-953
-100% -$31.6K
ATHX
5007
DELISTED
Athersys, Inc. Common Stock
ATHX
$0 ﹤0.01%
5
-83
-94% -$3.18K
ENDP
5008
DELISTED
Endo International plc
ENDP
-11,847
Closed -$830K
RDUS
5009
DELISTED
Radius Health, Inc.
RDUS
-700
Closed -$9K
OBCI
5010
DELISTED
Ocean Bio-Chem Inc
OBCI
-141
Closed
ACC
5011
DELISTED
American Campus Communities, Inc.
ACC
-8,354
Closed -$319K
NTUS
5012
DELISTED
Natus Medical Inc
NTUS
-500
Closed -$13K
PBIP
5013
DELISTED
Prudential Bancorp, Inc.
PBIP
-384
Closed -$4K
IRCP
5014
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
-945
Closed -$5K
ANAT
5015
DELISTED
American National Group, Inc. Common Stock
ANAT
-17
Closed -$2K
IIN
5016
DELISTED
IntriCon Corporation
IIN
$0 ﹤0.01%
16
-2,698
-99% -$19.2K
ISBC
5017
DELISTED
Investors Bancorp, Inc.
ISBC
-5,009
Closed -$55K
FMO
5018
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
-29
Closed -$4K
HBMD
5019
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
-1,135
Closed -$11K
SBM
5020
DELISTED
ProShares Short Basic Materials
SBM
-20
Closed -$2K
DRNA
5021
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-10
Closed
CXP
5022
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
-3,657
Closed -$92.8K
ADMS
5023
DELISTED
Adamas Pharmaceuticals
ADMS
-2,969
Closed -$54K
XLRN
5024
DELISTED
Acceleron Pharma
XLRN
$0 ﹤0.01%
2
-2,622
-100% -$73.9K
JTD
5025
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
-4
Closed

Similar funds

Tower Research Capital (TRC)'s Q3 2014 Portfolio in Review

As of Q3 2014, Tower Research Capital (TRC) held 5,559 positions worth $892M, up 15% from $778M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $142M of net new capital in Q3 2014, opening 1,359 new positions and adding to 1,658 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 5.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $106M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2014 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q3 2014, an estimated $23.8M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $106M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Value ETF in Q3 2014, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $892M portfolio in Q3 2014.
  • Tower Research Capital (TRC) opened 1,359 new positions and closed 897 in Q3 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 15% quarter-over-quarter to $892M.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2014, filed 31 Oct 2014.